United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read General business news Markel Group (NYSE: MKL) posts $2.3bn adjusted operating income in 2025, led by insurance turnaround Markel’s 2025 results reveal a strategic reset in reinsurance and a 16% insurance profit surge. Find out how the group is compounding value across segments. bySrinathFebruary 5, 2026